This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. To further the Universidad Central del Caribe (UCC) research capabilities and productivity, the Scientific Human Resources Development Unit (SHRDU) was created in the previous cycle of RCMI support to UCC. The Unit was created to be responsible for the professional development and continued education of junior and senior research faculty. In order to achieve the institutional RCMI goals of increasing translational research, the SHRDU will become the Scientific Resources Development Unit (SRDU), with the LONG-TERM OBJECTIVE of making the faculty independent researchers that are no longer dependent on minority earmark funding. The GOAL of the Unit is to increase UCC's capacity to perform world-class research and attract first-rate researchers.
The SPECIFIC AIMS of the SRDU for this cycle of support are: 1) Increase the critical mass of researchers at UCC involved in translational research;2) Increase the number of translational research projects performed at UCC;3) Provide support to investigators in pre- and post-award management;4) Increase the number of publications in high-impact peer-reviewed journals;5) Increase interdisciplinary inter-institutional research collaborations;6) Increase the Institution's capabilities to obtain non-minority external funding;7) Increase the amount of funding provided by non-federal sources of funding. Following the recommendation of the External Advisory Committee, our consultant and the assessment of the Unit, the SRDU will achieve its specific aims through five programs: 1) Faculty Recruitment and Retention Program;2) Translational Research Program;3) Translational Research Seminar Series; 4) Research Faculty Fellowship Program;and 5) Visiting Scholars Program. The SRDU address two primary problems characteristic of most minority institutions: difficulty in obtaining research support and the extensive administrative and teaching loads that limit research productivity. Funding of this Unit will forward our translational research agenda.
|Karl, Anett; Agte, Silke; Zayas-Santiago, Astrid et al. (2018) Retinal adaptation to dim light vision in spectacled caimans (Caiman crocodilus fuscus): Analysis of retinal ultrastructure. Exp Eye Res 173:160-178|
|Agte, Silke; Savvinov, Alexey; Karl, Anett et al. (2018) Müller glial cells contribute to dim light vision in the spectacled caiman (Caiman crocodilus fuscus): Analysis of retinal light transmission. Exp Eye Res 173:91-108|
|Suárez-Arroyo, Ivette J; Loperena-Alvarez, Yaliz; Rosario-Acevedo, Raysa et al. (2017) Ganoderma spp.: A Promising Adjuvant Treatment for Breast Cancer. Medicines (Basel) 4:|
|Maldonado-Martínez, Gerónimo; Hunter-Mellado, Robert F; Fernández-Santos, Diana et al. (2016) Persistent HIV Viremia: Description of a Cohort of HIV Infected Individuals with ART Failure in Puerto Rico. Int J Environ Res Public Health 13:ijerph13010050|
|Zueva, Lidia; Golubeva, Tatiana; Korneeva, Elena et al. (2016) Foveolar Müller Cells of the Pied Flycatcher: Morphology and Distribution of Intermediate Filaments Regarding Cell Transparency. Microsc Microanal 22:379-86|
|Martinez, Namyr A; Ayala, Alondra M; Martinez, Magdiel et al. (2016) Caveolin-1 Regulates the P2Y2 Receptor Signaling in Human 1321N1 Astrocytoma Cells. J Biol Chem 291:12208-22|
|de la Parra, Columba; Castillo-Pichardo, Linette; Cruz-Collazo, Ailed et al. (2016) Soy Isoflavone Genistein-Mediated Downregulation of miR-155 Contributes to the Anticancer Effects of Genistein. Nutr Cancer 68:154-64|
|Suárez-Arroyo, Ivette J; Rios-Fuller, Tiffany J; Feliz-Mosquea, Yismeilin R et al. (2016) Ganoderma lucidum Combined with the EGFR Tyrosine Kinase Inhibitor, Erlotinib Synergize to Reduce Inflammatory Breast Cancer Progression. J Cancer 7:500-11|
|Suárez-Arroyo, Ivette J; Feliz-Mosquea, Yismeilin R; Pérez-Laspiur, Juliana et al. (2016) The proteome signature of the inflammatory breast cancer plasma membrane identifies novel molecular markers of disease. Am J Cancer Res 6:1720-40|
|Pasaoglu, Taliha; Schikorski, Thomas (2016) Presynaptic size of associational/commissural CA3 synapses is controlled by fibroblast growth factor 22 in adult mice. Hippocampus 26:151-60|
Showing the most recent 10 out of 167 publications